But an association with improved overall survival failed to reach statistical significance ...

A cancer specialist explains the subtle warning signs that are easy to dismiss ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Former President Joe Biden has been diagnosed with a form of prostate cancer that has been described as “aggressive.” Obviously, that’s not good news for him and his family, but what does it mean in ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom.

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.